BILLING CODE 4163-18-P
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Solicitation of Nominations for Appointment to the Lead Exposure and Prevention
Advisory Committee
AGENCY: Centers for Disease Control and Prevention (CDC), Department of Health and
Human Services (HHS).
ACTION: Notice.
SUMMARY: In accordance with the Federal Advisory Committee Act, the Centers for Disease
Control and Prevention (CDC), within the Department of Health and Human Services (HHS), is
soliciting nominations for membership on the Lead Exposure and Prevention Advisory
Committee (LEPAC). The LEPAC is composed of not more than 15 members and not less than
half of the members shall be Federal members in fields associated with lead screening, the
prevention of lead exposure, and services for individuals and communities affected by lead
exposure.
DATES: Nominations for membership on the LEPAC must be received no later than [INSERT
DATE 30 DAYS AFTER PUBLICATION IN THE FEDERAL REGISTER]. Packages
received after this time will not be considered for the current membership cycle.
ADDRESSES: All nominations should be emailed to LEPAC@cdc.gov.
FOR FURTHER INFORMATION CONTACT: Paul Allwood, Ph.D., M.P.H., Designated
Federal Officer, Lead Exposure and Prevention Advisory Committee, National Center for
Environmental Health, Centers for Disease Control and Prevention, 4770 Buford Highway,
Atlanta, Georgia 30341. Telephone: (770) 488-6774; Email: PAllwood@cdc.gov.
SUPPLEMENTARY INFORMATION: Nominations are sought for individuals with expertise
in the fields of epidemiology, toxicology, mental health, pediatrics, early childhood education,
special education, diet and nutrition, and environmental health. Members may be invited to serve

for three-year terms. Selection of members is based on candidates’ qualifications to contribute to
the accomplishment of Lead Exposure and Prevention Advisory Committee (LEPAC) objectives.
The members of this Committee are selected by the Secretary of the Department of Health
and Human Services (HHS). The Committee’s objective is to advise the Secretary, HHS, and the
Director, Centers for Disease Control and Prevention (CDC)/Administrator, Agency for Toxic
Substances and Disease Registry on a range of activities to include: (1) review of Federal
programs and services available to individuals and communities exposed to lead; (2) review of
the current research on lead exposure to identify additional research needs; (3) review of and
identification of best practices, or the need for best practices regarding lead screening and the
prevention of lead exposure; (4) identification of effective services, including services relating to
healthcare, education, and nutrition for individuals and communities affected by lead exposure
and lead poisoning, including in consultation with, as appropriate, the lead exposure registry as
established in Public Law 114-322 Section 2203(b) (42 U.S.C. 300j-27); and (5) undertaking of
any other review or activities that the Secretary determines to be appropriate.
Annually as determined necessary by the Secretary or as required by Congress, the
Committee shall submit a report to include: (1) an evaluation of the effectiveness of the Federal
programs and services available to individuals and communities exposed to lead; (2) an
evaluation of additional lead exposure research needs; (3) an assessment of any effective
screening methods or best practices used or developed to prevent or screen for lead exposure; (4)
input and recommendations for improved access to effective services relating to healthcare,
education, or nutrition for individuals and communities impacted by lead exposure; and (5) any
other recommendations for communities affected by lead exposure, as appropriate.
At least half of the Committee will consist of Federal representatives from a range of
agencies that may include the Department of Housing and Urban Development; the
Environmental Protection Agency; the Consumer Product Safety Commission; the Centers for
Medicare and Medicaid Services; the Health Resources and Services Administration; the Food

and Drug Administration (FDA); the U.S. Department of Agriculture; the Occupational Safety
and Health Administration; the National Institute of Environmental Health Sciences; the U.S.
Geological Survey; and such additional Federal, state, tribal, and local public and private
officials as the Secretary deems necessary for the Committee to carry out its function. The rest of
the Committee will consist of non-Federal members. Only non-Federal members are being
solicited with this announcement.
HHS policy stipulates that committee membership be balanced in terms of points of view
represented and the committee’s function. Appointments shall be made without discrimination
on the basis of age, race, ethnicity, gender, sexual orientation, gender identity, HIV status,
disability, and cultural, religious, or socioeconomic status. Nominees must be U.S. citizens and
cannot be full-time employees of the U.S. Government. Current participation on Federal
workgroups or prior experience serving on a Federal advisory committee does not disqualify a
candidate; however, HHS policy is to avoid excessive individual service on advisory committees
and multiple committee memberships. Committee members are Special Government Employees,
requiring the filing of financial disclosure reports at the beginning of and annually during their
terms. CDC reviews potential candidates for LEPAC membership each year and provides a slate
of nominees for consideration to the Secretary of HHS for final selection. HHS notifies selected
candidates of their appointment as soon as the HHS selection process is completed. Note that the
need for different expertise varies from year to year and a candidate who is not selected in one
year may be reconsidered in a subsequent year.
Candidates should submit the following items:
•

Current curriculum vitae, including complete contact information (telephone numbers,
mailing address, email address).

•

At least one letter of recommendation from person(s) not employed by HHS. Candidates
may submit letter(s) from current HHS employees if they wish, but at least one letter

must be submitted by a person not employed by an HHS agency (e.g., CDC, National
Institutes of Health, FDA).
Nominations may be submitted by the candidate or by the person/organization
recommending the candidate.
The Director, Office of Strategic Business Initiatives, Office of the Chief Operating Officer,
Centers for Disease Control and Prevention, has been delegated the authority to sign Federal
Register notices pertaining to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic
Substances and Disease Registry.

Kalwant Smagh,
Director, Office of Strategic Business Initiatives,
Office of the Chief Operating Officer,
Centers for Disease Control and Prevention.

[FR Doc. 2024-15917 Filed: 7/18/2024 8:45 am; Publication Date: 7/19/2024]